Client Background
Veincentre had grown to be the UK’s preeminent provider of non-invasive venous insufficiency treatment, bridging the lack of NHS service provision for a potentially debilitating condition.
Shareholders Dr. David and Deborah West wished to find an investor that would provide capital to accelerate Veincentre’s roll-out plans and enable them to realise significant cash out.
Rickitt Mitchell was appointed to find and transact with an investor that could meet these objectives.